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Abstract: We describe the course and likely pathophysiology of impending anterior ischemic 
optic neuropathy (AION) and retinal vein occlusion in a 56-year-old man with polycythemia 
vera managed with interferon alpha for 2 years. Our patient presented with decreased vision, 
scintillating scotomata, and floaters. Fundus examination findings and results of a fluorescein 
angiogram led to the diagnosis of impending AION and retinal vein occlusion. Considering 
that both polycythemia vera and interferon have possible influences on vascular occlusion 
and optic disc edema, we stopped interferon treatment and immediately attempted to treat the 
polycythemia vera empirically with pentoxifylline and any interferon-associated inflammation 
with prednisone. Our patient experienced complete resolution of fundus abnormalities and return 
of normal vision within 3 weeks, which may be attributed to our successful treatment of both 
etiologies. Thus, further study is warranted to elucidate the treatment of both polycythemia vera 
and interferon-induced impending AION.
Keywords: optic disc edema, interferon alpha, vascular occlusion, Roth spot, autoantibody, 
pentoxifylline
Case report
A 56-year-old Caucasian male with polycythemia vera controlled with interferon alpha 
treatment for 2 years presented to our institution with decreased vision, greater on the 
right than left, scintillating scotomata, and floaters. His hematocrit the week prior was 
39.9%. On examination, his best corrected visual acuity was 20/20 in both eyes (OU). 
Intraocular pressures were 14 mmHg in the right eye (OD) and 12 mmHg in the left eye 
(OS). He saw 8/8 AO test plates OU with equal brightness sense OU. There was a trace 
afferent papillary defect OD. Fundus examination on the right showed nerve fiber layer 
swelling at 12 and 6 o’clock, a very distended and tortuous superior branch retinal vein, 
one flame-shaped peripapillary hemorrhage, and one preretinal hemorrhage alongside 
areas of ischemia at the inferior pole (Figure 1). The left eye showed one peripapillary 
hemorrhage with a white center (Roth spot) with slight retinal nerve fiber layer swelling 
at the optic disc margin superiorly and inferiorly, but much less venous distention 
(Figure 2). Fluorescein angiography confirmed impending retinal vein occlusion with 
delayed transit time (20 seconds for the right superior hemi vein), more in OD than 
OS, but no choroidal infarction. Interferon was stopped immediately, and the patient 
started pentoxifylline 400 mg every day to treat polycythemia vera, and prednisone 
40 mg every day to counter any interferon-induced inflammation. Within 3 weeks, his 
vision became clear, the afferent papillary defect resolved, and fundus examination 
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pressure or malignant hypertension. He also did not have a 
complete AION because resolution was complete. In fact, our 
patient’s optic disc edema was concentrated at the superior 
and inferior poles, corresponding to the locations of venous 
compromise. Thus, considering the associated retinal venous 
distention and hemorrhage, we attributed the patient’s optic 
disc edema to impending AION and his delayed filling on 
fluorescein angiogram to retinal vein occlusion. We attribute 
these fundus examination findings to axoplasmic stasis and 
retinal hemorrhage resulting from optic and retinal vascular 
occlusion and venous backflow,1 all likely secondary to 
complications of interferon and polycythemia vera. Interferon 
has been documented to cause occlusion directly, possibly 
from inflammation.2 Interferon may produce autoantibodies 
and incite inflammation in the vessels of the optic disc,2 
contributing to an impending AION. This can cause optic 
nerve ischemia and fiber swelling,1 which can progress further 
to retinal vein occlusion and hemorrhage, as well as to AION 
with permanent losses of visual field and visual acuity.3
The preretinal hemorrhages and Roth spots seen in 
our patient have been documented as complications with 
both interferon4 as well as myeloproliferative disorders.5 
 Polycythemia vera poses additional risk factors for retinal 
vein occlusion, including higher whole blood viscosity, 
reduced red cell deformability,6 and abnormal red cell 
adhesion. Diminished membrane fluidity of red blood cells 
plays a role in microvascular occlusion in patients with 
polycythemia vera.7 In addition, JAK2 kinase mutation 
in patients with polycythemia vera causes abnormal 
phosphorylation of CD 239 on red blood cells, which 
allows its ligation with the laminin alpha5 chain on the 
apical surface of endothelial cells.8 This adhesion has been 
demonstrated to be strong enough to withstand sheer stresses 
of postcapillary venules.8 Thus, polycythemia vera-associated 
red blood cell adhesion may be another strong factor in 
the pathophysiology of venous occlusion.6 Considering 
that both polycythemia vera and interferon are possible 
influences on vascular occlusion and optic disc edema and 
the pathophysiology described, we immediately attempted to 
treat the polycythemia vera empirically with pentoxifylline to 
increase red blood cell fluidity and the interferon-associated 
inflammation with prednisone. Our patient also had a history 
of hypotension to 95/65 mmHg, which was monitored, given 
that hypotension is a risk factor for AION.9 Our patient 
experienced complete resolution of fundus abnormalities 
and return of normal vision, which may be attributed to 
successful treatment of both etiologies, though there remains 
the possibility of spontaneous resolution. Thus, further study 
Figure 1 Fundus examination OD at presentation revealing nerve fiber layer 
swelling at 12 and 6 o’clock, a very distended and tortuous superior branch retinal 
vein, one flame-shaped peripapillary hemorrhage, and one preretinal hemorrhage 
alongside areas of ischemia at the inferior pole.
Abbreviation: OD, right eye.
Figure 2 Fundus examination OS at presentation showing one Roth spot with slight 
retinal nerve fiber layer swelling at the optic disc margin superiorly and inferiorly, 
but much less venous distention than OD.
Abbreviations: OD, right eye; OS, left eye.
revealed complete resolution of the aforementioned vascular 
abnormalities. He was slowly tapered down to prednisone 
7.5 mg every other day and maintained on pentoxifylline 
400 mg three times a day.
Discussion
Here we describe the course and likely pathophysiology 
of interferon alpha and polycythemia vera-associated 
impending AION, retinal vessel ischemia, and hemorrhage. 
Our patient’s bilateral optic disc edema did not have the 
supporting signs or symptoms of elevated intracranial 
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is warranted to elucidate the treatment of both polycythemia 
vera and interferon-induced impending AION.
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